Low-temperature inhalation administration of cannabinoid entities
US10064821B2 · kind B2 · utility
6Cited by
13References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2017 |
| Grant date | Sep 4, 2018 |
| Priority date | — |
| Expiry date | Jun 27, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M11/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cannabinoid material as active agent containing formulation comprising the active agent, an HFA propellant, and optionally a co-solvent is disclosed. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 50° C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.